Recombinant Proteins

MIP-5, CCL15, human: CCL15, a new human CC chemokine, was isolated from a human fetal spleen cDNA library. CCL15 cDNA encodes a predicted 113 amino acid (aa) protein containing a putative signal peptide of 21 amino acids that is cleaved to generate

MIP-5, CCL15, human: CCL15, a new human CC chemokine, was isolated from a human fetal spleen cDNA library. CCL15 cDNA encodes a predicted 113 amino acid (aa) protein containing a putative signal peptide of 21 amino acids that is cleaved to generate

NAP-2, CXCL7, human: Neutrophil Activating Peptide 2 (NAP-2) is proteolytically processed carboxyl-terminal fragments of platelet basic protein (PBP) which is found in the alpha-granules of human platelets. NAP-2 is a member of the CXC chemokines.

NAP-2, CXCL7, human: Neutrophil Activating Peptide 2 (NAP-2) is proteolytically processed carboxyl-terminal fragments of platelet basic protein (PBP) which is found in the alpha-granules of human platelets. NAP-2 is a member of the CXC chemokines.

NAP-2, CXCL7, human: Neutrophil Activating Peptide 2 (NAP-2) is proteolytically processed carboxyl-terminal fragments of platelet basic protein (PBP) which is found in the alpha-granules of human platelets. NAP-2 is a member of the CXC chemokines.

NOGGIN, human: Human NOGGIN &nbspNoggin belongs to a group of diffusible proteins which bind to ligands of the TGF-&beta family and regulate their activity by inhibiting their access to signaling receptors. Noggin was originally identified as a

NOGGIN, human: Human NOGGIN &nbspNoggin belongs to a group of diffusible proteins which bind to ligands of the TGF-&beta family and regulate their activity by inhibiting their access to signaling receptors. Noggin was originally identified as a

NOGGIN, human: Human NOGGIN &nbspNoggin belongs to a group of diffusible proteins which bind to ligands of the TGF-&beta family and regulate their activity by inhibiting their access to signaling receptors. Noggin was originally identified as a

Oncostatin M (209 a.a.

Oncostatin M (209 a.a.

Oncostatin M (209 a.a.

Oncostatin M (227 a.a.